Literature DB >> 26894887

Human Islet Amyloid Polypeptide N-Terminus Fragment Self-Assembly: Effect of Conserved Disulfide Bond on Aggregation Propensity.

Alexandre I Ilitchev1, Maxwell J Giammona1, Thanh D Do1, Amy G Wong2, Steven K Buratto1, Joan-Emma Shea1, Daniel P Raleigh2,3, Michael T Bowers4.   

Abstract

Amyloid formation by human islet amyloid polypeptide (hIAPP) has long been implicated in the pathogeny of type 2 diabetes mellitus (T2DM) and failure of islet transplants, but the mechanism of IAPP self-assembly is still unclear. Numerous fragments of hIAPP are capable of self-association into oligomeric aggregates, both amyloid and non-amyloid in structure. The N-terminal region of IAPP contains a conserved disulfide bond between cysteines at position 2 and 7, which is important to hIAPP's in vivo function and may play a role in in vitro aggregation. The importance of the disulfide bond in this region was probed using a combination of ion mobility-based mass spectrometry experiments, molecular dynamics simulations, and high-resolution atomic force microscopy imaging on the wildtype 1-8 hIAPP fragment, a reduced fragment with no disulfide bond, and a fragment with both cysteines at positions 2 and 7 mutated to serine. The results indicate the wildtype fragment aggregates by a different pathway than either comparison peptide and that the intact disulfide bond may be protective against aggregation due to a reduction of inter-peptide hydrogen bonding. Graphical Abstract ᅟ.

Entities:  

Keywords:  Amyloid; Atomic force microscopy; Diabetes; Electrospray ionization; IAPP; Ion mobility; Islet amyloid polypeptide; Peptide; Replica exchange molecular dynamics; T2DM; Type 2 diabetes mellitus; hIAPP; human Islet Amyloid Polypeptide

Mesh:

Substances:

Year:  2016        PMID: 26894887     DOI: 10.1007/s13361-016-1347-7

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  56 in total

Review 1.  Mechanistic studies of the process of amyloid fibrils formation by the use of peptide fragments and analogues: implications for the design of fibrillization inhibitors.

Authors:  Ehud Gazit
Journal:  Curr Med Chem       Date:  2002-10       Impact factor: 4.530

2.  A temperature predictor for parallel tempering simulations.

Authors:  Alexandra Patriksson; David van der Spoel
Journal:  Phys Chem Chem Phys       Date:  2008-02-25       Impact factor: 3.676

3.  Widespread amyloid deposition in transplanted human pancreatic islets.

Authors:  Gunilla T Westermark; Per Westermark; Christian Berne; Olle Korsgren
Journal:  N Engl J Med       Date:  2008-08-28       Impact factor: 91.245

Review 4.  The power of ion mobility-mass spectrometry for structural characterization and the study of conformational dynamics.

Authors:  Francesco Lanucara; Stephen W Holman; Christopher J Gray; Claire E Eyers
Journal:  Nat Chem       Date:  2014-04       Impact factor: 24.427

Review 5.  Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.

Authors:  Per Westermark; Arne Andersson; Gunilla T Westermark
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

6.  Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin.

Authors:  Daniel Sellin; Li-Mei Yan; Aphrodite Kapurniotu; Roland Winter
Journal:  Biophys Chem       Date:  2010-01-28       Impact factor: 2.352

7.  Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts.

Authors:  K J Potter; A Abedini; P Marek; A M Klimek; S Butterworth; M Driscoll; R Baker; M R Nilsson; G L Warnock; J Oberholzer; S Bertera; M Trucco; G S Korbutt; P E Fraser; D P Raleigh; C B Verchere
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

8.  Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus.

Authors:  A N Roberts; B Leighton; J A Todd; D Cockburn; P N Schofield; R Sutton; S Holt; Y Boyd; A J Day; E A Foot
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 9.  Aggregation of islet amyloid polypeptide: from physical chemistry to cell biology.

Authors:  Ping Cao; Andisheh Abedini; Daniel P Raleigh
Journal:  Curr Opin Struct Biol       Date:  2012-12-22       Impact factor: 6.809

10.  Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets.

Authors:  Z L Wang; W M Bennet; M A Ghatei; P G Byfield; D M Smith; S R Bloom
Journal:  Diabetes       Date:  1993-02       Impact factor: 9.461

View more
  5 in total

1.  Amyloidogenicity and cytotoxicity of des-Lys-1 human amylin provides insight into amylin self-assembly and highlights the difficulties of defining amyloidogenicity.

Authors:  Kyung-Hoon Lee; Alexander Zhyvoloup; Daniel Raleigh
Journal:  Protein Eng Des Sel       Date:  2019-12-13       Impact factor: 1.650

2.  Analysis of the Role of the Conserved Disulfide in Amyloid Formation by Human Islet Amyloid Polypeptide in Homogeneous and Heterogeneous Environments.

Authors:  Zachary Ridgway; Xiaoxue Zhang; Amy G Wong; Andisheh Abedini; Ann Marie Schmidt; Daniel P Raleigh
Journal:  Biochemistry       Date:  2018-05-14       Impact factor: 3.162

3.  His18 promotes reactive oxidative stress production in copper-ion mediated human islet amyloid polypeptide aggregation.

Authors:  Gengyang Huo; Wenyong Chen; Jianhua Wang; Xinxing Chu; Wei Xu; Bin Li; Yi Zhang; Binqian Xu; Xingfei Zhou
Journal:  RSC Adv       Date:  2020-02-04       Impact factor: 3.361

4.  Ameliorating amyloid aggregation through osmolytes as a probable therapeutic molecule against Alzheimer's disease and type 2 diabetes.

Authors:  Anchala Kumari; Pallavi Somvanshi; Abhinav Grover
Journal:  RSC Adv       Date:  2020-03-25       Impact factor: 4.036

5.  Fibrillation of Human Calcitonin and Its Analogs: Effects of Phosphorylation and Disulfide Reduction.

Authors:  Harshil K Renawala; Karthik B Chandrababu; Elizabeth M Topp
Journal:  Biophys J       Date:  2020-11-18       Impact factor: 4.033

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.